1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA MYH1 CTRPv2 pan-cancer AAC -0.085 0.01
mRNA HMGCS1 CTRPv2 pan-cancer AAC -0.085 0.01
mRNA LYPLAL1 CTRPv2 pan-cancer AAC 0.09 0.01
mRNA AXL CTRPv2 pan-cancer AAC -0.095 0.01
mRNA GCSAM CTRPv2 pan-cancer AAC -0.092 0.01
mRNA GLS2 CTRPv2 pan-cancer AAC 0.092 0.01
mRNA BFSP2 CTRPv2 pan-cancer AAC -0.089 0.01
mRNA UBE2G1 CTRPv2 pan-cancer AAC -0.089 0.01
mRNA C11orf65 CTRPv2 pan-cancer AAC -0.086 0.01
mRNA MAFA CTRPv2 pan-cancer AAC -0.086 0.01
Download CSV